GeneDx
GeneDx Q2 Revenues Grow 45 Percent Driven by Exome, Genome Tests
The company saw a 52 percent year-over-year increase in whole-exome and whole-genome testing volume during Q2, booking $50.7 million in revenues for this business segment.
Craig-Hallum Initiates Coverage of GeneDx With Buy Rating
The investment bank cited the firm's strong growth in its whole-exome and whole-genome sequencing businesses and a clear path to profitability.
360Dx Top 30 Slides 2 Percent in June
Of the 30 companies in the list, 13 companies saw their share prices rise, while 17 firms saw their stock prices decline.
GeneDx, Epic Systems Collaborate on Rapid Whole-Genome Sequencing for NICU Patients
GeneDx will integrate its rWGS services with Epic's electronic health record, connecting directly with software used to receive orders and send results.
In Brief This Week: Becton Dickinson; Delfi Diagnostics; OpGen; GeneDx; Angle
News items for the week of June 3, 2024.
May 1, 2024
360Dx Top 30 Falls 6 Percent in April
Mar 1, 2024
360Dx Top 30 Creeps up 1 Percent in February
Apr 28, 2023